Sandra Favela v. Teva Pharmaceuticals, USA, Inc. et al
| Sandra Favela |
| TEVA WOMEN'S HEALTH, LLC, Teva Pharmaceuticals USA Inc, The Cooper Companies Inc, Coopersurgical Inc, Teva Branded Pharmaceutical Products R and D, Inc. and Teva Women's Health Inc |
| 1:2021cv00858 |
| March 1, 2021 |
| US District Court for the Northern District of Georgia |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1446 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 1, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 18
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021.(tmf)
|
| Civil Case Terminated. (tmf) |
|
Filing 17
TENTH AMENDMENT TO GENERAL ORDER 20-01 RE: COURT OPERATIONS UNDER THE EXIGENT CIRCUMSTANCES CREATED BY COVID-19 AND RELATED CORONAVIRUS. Signed by Judge Thomas W. Thrash, Jr. on 1/27/21. (aar)
|
| Filing 16 Case transferred in from District of California Central; Case Number 2:21-cv-01313. Original file certified copy of transfer order and docket sheet received. |
| Filing 15 Conditional Transfer Order - CTO 9 from the United States Judicial Panel on Multidistrict Litigation, MDL 2974, transferring case to USDC, Northern District of Georgia and assigned to Honorable Leigh Martin May. Case transferred electronically. (MD JS-6. Case Terminated.) (lom) [Transferred from California Central on 3/1/2021.] |
|
Filing 14
ORDER SETTING SCHEDULING CONFERENCE by Judge Philip S. Gutierrez. Scheduling Conference set for 4/19/2021 at 02:00 PM. (wm) [Transferred from California Central on 3/1/2021.]
|
|
Filing 13
STANDING ORDER REGARDING NEWLY ASSIGNED CASES by Judge Philip S. Gutierrez. (ji) [Transferred from California Central on 3/1/2021.]
|
| Filing 12 NOTICE TO PARTIES OF COURT-DIRECTED ADR PROGRAM filed. (ghap) [Transferred from California Central on 3/1/2021.] |
| Filing 11 NOTICE OF ASSIGNMENT to District Judge Philip S. Gutierrez and Magistrate Judge Jacqueline Chooljian. (ghap) [Transferred from California Central on 3/1/2021.] |
| CONFORMED FILED COPY OF COMPLAINT against Defendants CooperSurgical, Inc., Teva Branded Pharmaceutical Products R and D, Inc., Teva Pharmaceuticals, USA, Inc., Teva Womens Health, Inc., Teva Womens Health, LLC, The Cooper Companies, Inc. Jury Demanded., filed by plaintiff Sandra Favela. (FILED IN STATE COURT ON 1/7/2021 SUBMITTED ATTACHED EXHIBIT B) (ghap) [Transferred from California Central on 3/1/2021.] |
| Filing 10 CERTIFICATE OF SERVICE filed by Defendants CooperSurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Womens Health, Inc., The Cooper Companies, Inc., re Notice of Removal (Attorney Civil Case Opening),,, #1 , Certificate/Notice of Interested Parties, #3 , Civil Cover Sheet (CV-71) #2 served on 02/12/2021. (Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 9 ANSWER to Notice of Removal (Attorney Civil Case Opening),,, #1 filed by Defendant The Cooper Companies, Inc..(Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 8 ANSWER to Notice of Removal (Attorney Civil Case Opening),,, #1 filed by Defendant Teva Womens Health, LLC.(Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 7 ANSWER to Notice of Removal (Attorney Civil Case Opening),,, #1 filed by Defendant Teva Womens Health, Inc..(Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 6 ANSWER to Notice of Removal (Attorney Civil Case Opening),,, #1 filed by Defendant Teva Pharmaceuticals USA, Inc..(Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 5 ANSWER to Notice of Removal (Attorney Civil Case Opening),,, #1 filed by Defendant Teva Branded Pharmaceutical Products R&D, Inc..(Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 4 ANSWER to Notice of Removal (Attorney Civil Case Opening),,, #1 filed by Defendant CooperSurgical, Inc..(Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 3 NOTICE of Interested Parties filed by Defendants CooperSurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Womens Health, Inc., Teva Womens Health, LLC, The Cooper Companies, Inc., (Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 2 CIVIL COVER SHEET filed by Defendants CooperSurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Womens Health, Inc., Teva Womens Health, LLC, The Cooper Companies, Inc.. (Jones, Allison) [Transferred from California Central on 3/1/2021.] |
| Filing 1 NOTICE OF REMOVAL from Los Angeles Superior Court, case number 21STCV00578 Receipt No: ACACDC-30524638 - Fee: $402, filed by Defendants The Cooper Companies, Inc., Teva Pharmaceuticals USA, Inc., Teva Womens Health, Inc., CooperSurgical, Inc., Teva Womens Health, LLC, Teva Branded Pharmaceutical Products R&D, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D) (Attorney Allison Lenore Jones added to party CooperSurgical, Inc.(pty:dft), Attorney Allison Lenore Jones added to party Teva Branded Pharmaceutical Products R&D, Inc.(pty:dft), Attorney Allison Lenore Jones added to party Teva Pharmaceuticals USA, Inc.(pty:dft), Attorney Allison Lenore Jones added to party Teva Womens Health, Inc.(pty:dft), Attorney Allison Lenore Jones added to party Teva Womens Health, LLC(pty:dft), Attorney Allison Lenore Jones added to party The Cooper Companies, Inc.(pty:dft))(Jones, Allison) [Transferred from California Central on 3/1/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
